HIF-1α appears to be preferentially expressed in CCA tissues, rather than in the neighboring normal biliary epithelium [152], and being such a relevant element in sustaining tumor chemoresistance and immune evasion, many hypoxia-targeting strategies are now under investigation for cancer therapy [153]. The gene discussed is HIF1A; the disease is cholangiocarcinoma.